Skip to content

Study on Female Patients' Mammographic Texture Features

A Cohort Study on feMale Patients' mammogRaphic texturE featureS: the COMPRESS Trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06469606
Acronym
COMPRESS
Enrollment
200
Registered
2024-06-21
Start date
2024-06-17
Completion date
2038-12-15
Last updated
2026-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence, Breast Cancer, Mammography

Brief summary

Mammography is the most common method for breast imaging, and it provides information for model building and analysis. Radiomics applied to mammography has the potential to revolutionize clinical decision-making by providing valuable insights into risk assessment and disease detection. Despite this, the influence of imaging parameters and clinical and biological factors on radiological texture features remains poorly understood. There is a pressing need to overcome the obstacle of system-inherent effects on mammographic images to facilitate the translation of radiological texture features into routine clinical practice by enabling reliable and robust AI-based or AI-aided decision-making. Furthermore, understanding the relationship between imaging parameters, textural features, and clinical and biological information supports the clinical use of AI. The objective of this study is to evaluate AI methods for clinical practice and to study how it relates to clinical factors and biological features.

Interventions

DEVICEAI tool

Both the arms will undergo the use of "AI tool" developed in the group. The tool will be trained to detect outcomes.

Sponsors

Tampere University Hospital
Lead SponsorOTHER
Tampere University
CollaboratorOTHER
Kuopio University Hospital
CollaboratorOTHER
University of Eastern Finland
CollaboratorOTHER
University of Turku
CollaboratorOTHER
University of Oulu
CollaboratorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Candidate is a biological female aged 18 years or above; * Candidate is willing and able to give informed consent and gives their written consent for the participation in the study; * There is a clinical indication for a uni- or bilateral mastectomy

Exclusion criteria

* Candidate lacks the capacity to provide informed consent; * Candidate has breast implants

Design outcomes

Primary

MeasureTime frameDescription
Mammographic texture featuresThrough study completion, an average of 5 yearAim: to evaluate how imaging parameters affect the mammographic texture features

Secondary

MeasureTime frameDescription
Biological featuresthrough study completion, an average of 10 yearAim: To evaluate whether there is an interplay between mammographic texture feature parameters and pathological and biological features (e.g., breast cancer biomarkers)

Countries

Finland

Contacts

CONTACTOtso Arponen, MD, PhD
otso.arponen@tuni.fi+3583311611

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 6, 2026